Atlas Trials

Chidamide With R-CHOP Regimen for DLBCL Patients

Clinical trial NCT03201471 · UNKNOWN

Trial details

NCT number
NCT03201471
Sponsor
First Affiliated Hospital of Zhejiang University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Diffuse Large B Cell Lymphoma
Start date
2017-08-20
Primary completion
2019-12-30
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.